(PharmaNewsWire.Com, July 08, 2017 ) According to the latest forecast study, untreated periodontal disease results in chronic inflammation that leads to increased insulin resistance, reduced glucose tolerance and an increased risk of diabetic complications. To overcome this issue, many research and therapeutic development are in process for the treatment of periodontal disease. Considering this fact, a study titled “Periodontal Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016-2024” have been freshly broadcasted to the vast repository of Market Research Hub (MRH). The report on global periodontal therapeutics market, analyzes the current and future prospects of the market, with a prime focus on major regions including North America, Europe, Asia-Pacific and Rest of the World.
Periodontal disease is a chronic bacterial infection of the periodontium affecting the tissues surrounding and supporting the teeth. In the initial section, the report consists of an executive summary that provides information about the products, its segments and sub-segments, along with a market snapshot and comparative analysis by geography, in terms of revenue % for the year 2016. A detailed overview of market dynamics, including the drivers, restraints and prospects of the periodontal therapeutics market, along with porter’s analysis, and value chain analysis of the global market, has been offered in the study. As per the research findings, the global periodontal disease therapeutics market will exhibit a CAGR of 8.7% from 2016 to 2024, rising to an estimated value of US$537.2 mn by 2024.
The research study finds that to treat bacterial infection diseases as an infectious disease, numerous therapeutic strategies aimed at eradication of periodontal pathogens have been studied over the years, including local and systemic delivery of antimicrobial and antibiotic agents. Periodontal therapeutics are the non-surgical treatment for treatment of periodontal diseases. As per the report, the factors such as rise in incidence of periodontal disease across the world, rising diabetes patient pool, increasing new product innovation and research and development activities will fuel the global periodontal therapeutics market. Some other factors such as product patient expiry, growing awareness about oral health, increasing use of tobacco will also drive the global periodontal therapeutics market over the report’s forecast period.
Moreover, the research study segments the market by product, distribution channel and regions. In terms of periodontal therapeutics products, the global market has been segmented into systemic antibiotics and local antibiotics. Among these, the segment of systemic antibiotics held a clear dominance in 2016. Factors such as product affordability, availability, and high market penetration will continue to drive the demand for systemic antibiotics for the treatment of periodontal diseases. The report also analyzes that the segment is predicted to continue to remain at top in terms of revenue. Apart from that, the segment of local antibiotics is expected to lead in terms of growth rate. On the basis of end users, the market is segmented as hospitals pharmacies, retail pharmacies, drug stores and E-Commerce.
The study further presents competitive landscape of the market by profiling key market players, such as 3M, Valeant Pharmaceuticals International, Inc., Den-Mat Holdings, LLC Dexcel Pharma, Galderma S.A. among others
About Market Research Hub:
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
